Dry Eye Syndrome Market size was over USD 6.98 billion in 2024 and is anticipated to exceed USD 18.03 billion by the end of 2037, witnessing over 7.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of dry eye syndrome is evaluated at USD 7.4 billion.
The growth of the market can primarily be ascribed to the rise in the number of people suffering with dry eye syndrome and higher spending on its treatment. Moreover, there has been a high prevalence from dry eyes owing to various other diseases such as thyroid disorders, diabetes, arthritis, and others, that is expected to boost the market’s growth in the upcoming years. By the end of 2027, the total cost of dry eye treatments is anticipated to reach over USD 6.6 billion across the globe.
The laser treatment is expected to cause the problems with dry eyes as the after results. Therefore, a rise in laser procedures is anticipated to boost the growth of the market. After having laser eye surgery, up to 95% of patients may develop dry eyes, that occur when the eyes produce fewer tears. Furthermore, the market growth is also expected to grow on the account of higher use of eye drops, followed by rise in geriatric population worldwide. It is commonly found more among aged population, as it is a disease of the tear film, and ocular surface that requires regular treatment and checks.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
7.5% |
Base Year Market Size (2024) |
USD 6.98 billion |
Forecast Year Market Size (2037) |
USD 18.03 billion |
Regional Scope |
|
End-user (Hospitals, Eye Clinics)
The global dry eye syndrome market is segmented and analyzed for demand and supply by end user into hospitals, eye clinics, and others. Out of which, the eye clinics segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the higher demand and greater number of eye clinics and optometrists present all around the world. Furthermore, eye clinics have the specialty in providing treatment for the eye disorders, that leads to better facilities and advanced technique adoption for the treatment of the diseases, and it is further expected to boost the segment’s growth in the market. In 2022, the United States have nearly 1000 eye surgery clinics. Moreover, in 123 countries, there are around 300,000 optometrists. Furthermore, according to the World Economic Forum, to meet the global needs, the world needs around 14 million optometrists.
Treatment (Nutritional Supplements, Surgery)
Moreover, the global dry eye syndrome market can be segmented by treatment into nutritional supplements, and surgery. Out of these, the nutritional supplements segment is expected to hold the largest share over the forecast period. This can be attributed to an upsurge in the intake of dietary supplements in the form of vitamin D and vitamin B12 that helps in providing relief from the symptoms such as inflammation and alleviating burning. In addition, mineral oils are also present in the eye drops that treat mild to moderate dry eye disorders, and it is predicted to surge the growth of the segment in the market.
Our in-depth analysis of the global market includes the following segments:
By Type |
|
By Diagnosis |
|
By End User |
|
By Treatment |
|
North American Market Forecast
The North American dry eye syndrome market is projected to hold the largest market share by the end of 2037. The growth of the market can be ascribed to the higher number of people suffering from dry eye disease. Around 16 million to 49 million people in America have dry eyes, which make up approximately 15% of the population. Furthermore, the region’s market growth is also boosted on the account of the higher use of eye drops. In the United States, nearly 120 million Americans used eye drops and eye wash in 2020, and the count is expected to increase to around 123 million by 2024. In addition, there has been a surge in the expansion of eye products, along with the expansion in ocular implants which is further predicted to increase the market’s growth in the region.
APAC Market Statistics
On the other hand, the Asia Pacific region is estimated to witness the fastest growth by the end of 2037, backed by the increase in the older population percentage, that are more prone to dry eye disorders. Moreover, the population is also increasing, that is expected to surge the number of dry eye syndrome cases in the region, which in turn is projected to boost the growth of the dry eye syndrome market in the Asia Pacific region.
Alcon launched its latest innovation, Systane iLux2 MGD Thermal Pulsation system, it enhances the dry eye care. This new imaging technology capture HD videos and infrared photos and enables patients to have better understanding about their problem.
Novartis AG announced the acquisition of Xiidra, the first ever prescription approved to treat the early signs and symptoms of dry eye problems by preventing inflammation caused by the disease.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?